As of 9:30 AM on the 27th, Celltrion is trading at 331,500 KRW, up 0.61% from the previous day. This represents a 37.55% increase compared to October 30. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net purchased 9,127 shares, while foreigners and institutions have net purchased 22,819 shares and net sold 53,806 shares, respectively.


On November 25, Celltrion became a market topic with a 23% increase following news of clinical trials for a COVID-19 antibody treatment.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing